Recent advancements in the field of diabetes treatment have introduced a new class of medications known as GLP-1 receptor agonists. These drugs work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://macietnau769447.bloguerosa.com/39664670/new-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide